|
VPS24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47930000471419E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.43030001573419E-09 |
| Normal-vs-Stage2 |
1.398180E-02 |
| Normal-vs-Stage3 |
6.859900E-02 |
| Normal-vs-Stage4 |
1.495020E-01 |
| Stage1-vs-Stage2 |
5.398800E-01 |
| Stage1-vs-Stage3 |
9.944200E-02 |
| Stage1-vs-Stage4 |
6.392200E-01 |
| Stage2-vs-Stage3 |
4.853000E-01 |
| Stage2-vs-Stage4 |
9.864600E-01 |
| Stage3-vs-Stage4 |
6.137000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.77619996067602E-09 |
| Normal-vs-AfricanAmerican |
2.194700E-04 |
| Normal-vs-Asian |
4.005400E-01 |
| Caucasian-vs-AfricanAmerican |
4.446000E-01 |
| Caucasian-vs-Asian |
6.158400E-01 |
| AfricanAmerican-vs-Asian |
7.943000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22839524610663E-11 |
| Normal-vs-Female |
2.803400E-01 |
| Male-vs-Female |
7.71230000000678E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.581500E-04 |
| Normal-vs-Extreme_Weight |
3.3408054100903E-11 |
| Normal-vs-Obese |
8.263400E-03 |
| Normal-vs-Extreme_Obese |
3.320200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.485220E-01 |
| Normal_Weight-vs-Obese |
2.978000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.767400E-01 |
| Extreme_Weight-vs-Obese |
7.024000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.644200E-01 |
| Obese-vs-Extreme_Obese |
2.657200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.883000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.43229999999928E-05 |
| Normal-vs-Age(61-80Yrs) |
3.57029994457747E-09 |
| Normal-vs-Age(81-100Yrs) |
3.563400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.823600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.998400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.387750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.174030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.739000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.723600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.21229948091673E-10 |
| Normal-VS-Type2 PRCC |
5.85039999999593E-05 |
| Normal-VS-KIRP CIMP |
3.123200E-01 |
| Normal-VS-Unclassified PRCC |
7.461600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.668800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.964730E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.506970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.758500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.280000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.811700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08830000011828E-07 |
| Normal-vs-N1 |
3.465800E-01 |
| Normal-vs-N2 |
4.365200E-01 |
| N0-vs-N1 |
1.508090E-02 |
| N0-vs-N2 |
3.330000E-01 |
| N1-vs-N2 |
8.013600E-01 |
|
|
